
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Mar 03, 2026 01:29 am UTC| Governance Health
The U.S. Centers for Disease Control and Prevention (CDC) is reinforcing its message that measles vaccination remains the most effective protection against the highly contagious disease, as cases climb to their highest...

Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
Feb 25, 2026 23:43 pm UTC| Politics Health Law
Two Democratic state attorneys general have launched a multistate lawsuit against the Trump administration, challenging recent changes to the federal childhood vaccine schedule that public health experts warn could reduce...

Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Feb 23, 2026 10:39 am UTC| Business Health
Novo Nordisk shares plunged more than 10% in mid-morning trading in Copenhagen on Monday after the pharmaceutical giant announced that its experimental obesity drug, CagriSema, failed to meet a primary endpoint in a...

Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Feb 21, 2026 03:05 am UTC| Business Health Governance
Vanda Pharmaceuticals (NASDAQ: VNDA) has secured FDA approval for its new drug, BYSANTI (milsaperidone), marking a significant milestone for the biotech company. The treatment is approved for Bipolar I disorder manic...

Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Feb 17, 2026 13:21 pm UTC| Insights & Views Health
Intermittent fasting has become a buzzword in nutrition circles, with many people looking to it as a way to lose weight or improve their health. But new research from the Cochrane Collaboration shows intermittent fasting...

Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Feb 13, 2026 08:30 am UTC| Business Health
Novartis announced that its investigational drug Vanrafia has successfully demonstrated the ability to slow kidney function decline in adults living with IgA nephropathy (IgAN), a chronic and progressive autoimmune kidney...

Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Feb 12, 2026 02:31 am UTC| Business Health Governance
Novocure (NASDAQ: NVCR) stock soared more than 30% in extended trading Wednesday after the U.S. Food and Drug Administration (FDA) approved its Optune Pax device for the treatment of locally advanced pancreatic cancer. The...